Latest Equity Funding News

Deal headlines and big drill hits shared the stage with a brutal sell-off in a handful of tiny raisings. The week’s biggest winners were backed by clear news; the biggest losers showed what happens when buyers vanish after a halt.

Small caps stole the spotlight, with a handful of stocks doubling on deal news and early-stage project updates. Large miners were steadier, but even they couldn’t fully escape the week’s sharp gap moves.

Horizon Minerals has successfully raised A$175 million through a two-tranche institutional placement, complemented by a planned A$10 million share purchase plan, to fund the development of its Black Swan Processing Hub near Kalgoorlie.

360 Capital REIT reported a 63.2% rise in statutory profit to $3.1 million for H1 2026, maintaining distributions and expanding its portfolio with a $10 million Sydney apartment block investment.

Morphic Ethical Equities Fund Limited reported a half-year profit after tax of $1.26 million for December 2025, declaring a fully franked 1 cent dividend and continuing its share buy-back program.

The CD Private Equity Fund Series reported robust performance in 2025, with improved exit activity and solid distributions despite currency headwinds. The funds continue to focus on asset-by-asset realisations while exploring portfolio liquidity options.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

A single drill program in WA delivered a once-a-year spike, while several small caps fell hard after reopening with price gaps. This week also saw big money raised for gold and uranium builds, and a run of resource upgrades across critical minerals.

The Supreme Court of New South Wales has approved the scheme of arrangement for Adamantem Capital Fund II’s acquisition of Apiam Animal Health, marking a pivotal step toward the deal’s completion and the suspension of Apiam shares on the ASX.

Anax Metals is set to release an updated feasibility study for its Whim Creek project, reflecting soaring commodity prices and progressing funding talks to push the project into development.

Apiam Animal Health shareholders have overwhelmingly approved the proposed acquisition by Adamantem Capital-controlled entities, clearing a critical hurdle for the $500 million deal.

Brightstar Resources has successfully raised $180 million through a $175 million institutional placement and a $5 million share purchase plan, fully funding its Goldfields development and advancing the Sandstone project towards a final investment decision.